Kynam Capital Management, LP Vera Therapeutics, Inc. Transaction History
Kynam Capital Management, LP
- $953 Million
- Q1 2024
A detailed history of Kynam Capital Management, LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 1,526,787 shares of VERA stock, worth $58 Million. This represents 6.91% of its overall portfolio holdings.
Number of Shares
1,526,787
Previous 3,650,339
58.17%
Holding current value
$58 Million
Previous $56.1 Million
17.27%
% of portfolio
6.91%
Previous 6.28%
Shares
10 transactions
Others Institutions Holding VERA
# of Institutions
173Shares Held
52.7MCall Options Held
117KPut Options Held
290K-
Avoro Capital Advisors LLC New York, NY5.27MShares$200 Million2.74% of portfolio
-
Black Rock Inc. New York, NY3.32MShares$126 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.17MShares$120 Million11.79% of portfolio
-
Abingworth LLP London, X02.96MShares$112 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$106 Million7.01% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.03B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...